Fjarde AP Fonden Fourth Swedish National Pension Fund Has $10.39 Million Stock Holdings in Waters Corporation $WAT

Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in shares of Waters Corporation (NYSE:WAT) by 138.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,880 shares of the medical instruments supplier’s stock after acquiring an additional 20,247 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Waters were worth $10,387,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Elevation Point Wealth Partners LLC acquired a new position in Waters in the 1st quarter worth about $496,000. Strs Ohio raised its stake in shares of Waters by 1,886.7% during the 1st quarter. Strs Ohio now owns 28,350 shares of the medical instruments supplier’s stock worth $8,443,000 after purchasing an additional 26,923 shares in the last quarter. Keybank National Association OH lifted its holdings in shares of Waters by 113.0% during the 1st quarter. Keybank National Association OH now owns 3,876 shares of the medical instruments supplier’s stock valued at $1,154,000 after buying an additional 2,056 shares during the last quarter. Physician Wealth Advisors Inc. lifted its holdings in shares of Waters by 253.1% during the 1st quarter. Physician Wealth Advisors Inc. now owns 173 shares of the medical instruments supplier’s stock valued at $52,000 after buying an additional 124 shares during the last quarter. Finally, Root Financial Partners LLC grew its stake in shares of Waters by 72.2% in the 1st quarter. Root Financial Partners LLC now owns 198 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 83 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Performance

Shares of NYSE WAT opened at $378.62 on Friday. The business’s 50-day simple moving average is $351.53 and its 200-day simple moving average is $347.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.13 and a current ratio of 1.79. Waters Corporation has a 52 week low of $275.05 and a 52 week high of $414.15. The firm has a market cap of $37.18 billion, a price-to-earnings ratio of 48.11, a P/E/G ratio of 2.29 and a beta of 1.20.

Waters (NYSE:WAT) last posted its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share for the quarter, topping the consensus estimate of $2.31 by $0.39. Waters had a return on equity of 15.60% and a net margin of 11.91%.The firm had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.20 billion. During the same period in the previous year, the company earned $2.25 EPS. The company’s revenue for the quarter was up 91.4% on a year-over-year basis. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. As a group, equities research analysts expect that Waters Corporation will post 14.51 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. The Goldman Sachs Group upgraded Waters to a “strong-buy” rating in a report on Wednesday, April 1st. Sanford C. Bernstein initiated coverage on shares of Waters in a research note on Friday, June 26th. They issued an “outperform” rating and a $435.00 target price for the company. Wells Fargo & Company boosted their target price on shares of Waters from $355.00 to $370.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 14th. HSBC increased their price target on shares of Waters from $415.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, June 3rd. Finally, Bank of America raised their price target on shares of Waters from $370.00 to $400.00 and gave the company a “neutral” rating in a report on Tuesday, June 2nd. Four research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $396.68.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.